Athlete’s Foot Treatment: Introduction
- Athlete’s foot is a common fungal infection of feet that causes the scaling and blistering of the soles, fissures at toes, painful and burning sensations, and itching rashes. The athlete’s foot is also known as tinea pedis.
- Athlete’s foot infection spreads in the warmth and moist conditions, especially inside the shoes. It commonly affects the area between the toes.
Read Report Overview – https://www.transparencymarketresearch.com/athletes-foot-treatment-market.html
- It is a contagious disease and spreads from person to person, or by walking on contaminated surfaces. There are different types of fungus that can cause the athlete’s foot and can be contracted through different sites such as fitness gyms, communal showers, swimming pool, from contaminated socks and shoes.
- Athlete’s foot can be treated with home remedies. Moreover, several over-the-counter treatments are available for treating athlete’s foot.
Athlete’s Foot Treatment: Key Drivers
- The global athlete’s foot treatment market is primarily driven by high prevalence and rise in incidence rates of athlete’s foot across the globe
- It is estimated that around 70% of people across the globe are likely to develop athlete’s foot at some point
- Moreover, easy availability of over-the-counter (OTC) treatment for the athlete’s foot, new product development, and low cost are likely to drive the market during the forecast period
Request Brochure of Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=43694
Antifungals Drug Class Segment to Dominate Global Market
- In terms of drug class, the global athlete’s foot market can be segmented into antifungal and corticosteroids. The antifungal segment is projected to dominate the global market during the forecast period.
- Antifungals are first line of treatment used for athlete’s foot. Most commonly used antifungal drugs are clotrimazole, econazole, ketoconazole, miconazole, terbinafine, griseofulvin, itraconazole, terbinafine, and sulconazole.
Retail Pharmacies Segment to Offer Attractive Opportunity
- In terms of distribution channel, the global athlete’s foot treatment market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies
- The retail pharmacies segment is projected to dominate global athlete’s foot treatment market and is estimated to grow at highest CAGR during the forecast period
Request for Custom Research – https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=43694
Asia Pacific Athlete’s Foot Treatment Market to Expand Rapidly
- In terms of region, the global athlete’s foot treatment market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is projected to dominate the global market during the forecast period.
- High prevalence of athlete’s foot in the region, well-established health care facilities, and high awareness about athlete’s foot are likely to contribute to dominant share of the region during the forecast period
- The athlete’s foot treatment market in Asia Pacific is projected to grow at the highest CAGR during the forecast period. Key factors attributable to high CAGR in Asia Pacific are rapidly growing number of patient population with athlete’s foot, large number of retail pharmacies stores, and improving health care infrastructure.
- Moreover, high growth rate of health care industry in Asia Pacific, easy access to health care facilities, and increase in investments in health care by leading market players in the Asia Pacific are estimated to fuel the growth of the market in the region
Pre Book Athletes Foot Treatment Market Report – https://www.transparencymarketresearch.com/checkout.php?rep_id=43694<ype=S
Key Players Operating in Global Market
The global athlete’s foot treatment market is highly fragmented with a large number of international players holding key market share in global market. Key players operating in the global athlete’s foot treatment market are:
- Mylan N.V.
- Novartis AG
- Pfizer Inc.
- Merck & Co., Inc.
- Sanofi-Aventis
- Bayer AG
- Enzon Pharmaceuticals, Inc.
- GlaxoSmithKline plc
- Abbott Laboratories
- Teva Pharmaceutical Industries Ltd.
More Trending Reports by Transparency Market Research –
Self injection Device Market: https://www.prnewswire.com/news-releases/presence-of-large-insulin-dependent-diabetic-population-expand-avenue-in-self-injection-device-market-pen-injectors-to-account-for-sizable-revenue-share-says-tmr-301260639.html
Separation Technology Market: https://www.prnewswire.com/news-releases/cell-separation-technology-market-to-clock-cagr-of–12-from-2019-to-2027-stem-cell-research-to-account-for-colossal-revenue-streams-notes-tmr-301086765.html
About Us
Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact
Transparency Market Research,
90 Sate Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
